SCHEMBL223041

SCHEMBL223041

ON1CCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL569843 0.95
SCHEMBL25431804 0.91
SCHEMBL25432592 0.87
SCHEMBL16145787 0.84
SCHEMBL57382 0.84
Hydrochloric Acid SCHEMBL6339950 0.80
Ammonia Solution, Strong SCHEMBL15121523 0.80
SCHEMBL1360 0.80
SCHEMBL2250577 0.80
Hydrochloric Acid SCHEMBL3410461 0.80

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 2453 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3752517-B1 CYCLIN-DEPENDENT KINASE DEGRADERS AND METHODS OF USE DANA FARBER CANCER INST INC (US) 2025-04-09 EP claimed
EP-3885337-B1 FTO INHIBITORS NAT INSTITUTE OF BIOLOGICAL SCIENCES BEIJING (CN) 2025-01-15 EP claimed
WO-2025002179-A1 HETEROTRICYCLIC N-[1-(2-BENZOFURANYL)-METHYL]-UREA DERIVATIVES AS PI3K ALPHA INHIBITORS FOR THE TREATMENT OF CANCER LAEKNA PHARMACEUTICAL NINGBO CO., LTD. (CN) 2025-01-02 WO claimed
CN-119143648-A Azetidine trichloroacetimidate and preparation method and application thereof 中国科学技术大学 2024-12-17 CN claimed
CN-118339168-A Fused ring heterocyclic derivative and application thereof in medicine 西藏海思科制药有限公司 2024-07-12 CN claimed
CN-118290322-A Aromatic molecules for the treatment of pathological conditions 赛尼欧普罗有限责任公司 2024-07-05 CN claimed
US-20240197711-A1 Combination Therapy for Cancer Treatment REGENTS OF THE UNIVERSITY OF MICHIGAN 2024-06-20 US claimed
WO-2024107393-A1 TRICYCLIC COMPOUNDS SCHRÖDINGER, INC. (US) 2024-05-23 WO claimed
CN-112654621-B Substituted naphthyridinone compounds useful as T cell activators 百时美施贵宝公司 2024-05-14 CN claimed
WO-2024083257-A1 SOS1 PROTEIN DEGRADATION AGENT AND USE THEREOF 上海领泰生物医药科技有限公司 2024-04-25 WO claimed
WO-1993013063-A1 POLYAZETIDINOL CONTAINING MATERIALS PPG INDUSTRIES, INC. (US) 1993-07-08 WO claimed
EP-0161722-B1 PREPARATION OF 1-SUBSTITUTED AZETIDINE-3-OL DERIVATIVES SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) 1990-04-04 EP claimed
EP-0073011-B1 1-ARYLOXY-3-ALKINYL-AMINO-2-PROPANOLS AND A METHOD FOR THEIR PREPARATION BOEHRINGER INGELHEIM KG (DE) 1986-04-02 EP claimed
EP-0073016-B1 1-ARYLOXY-3-ALKYLAMINO-2-PROPANOLS AND PROCESSES FOR THEIR PREPARATION BOEHRINGER INGELHEIM KG (DE) 1985-11-27 EP claimed
US-4474777-A ATHEROSCLEROSIS HOFFMANN-LA ROCHE INC. (US) 1984-10-02 US claimed
EP-0035734-B1 1-(ACYLAMINO-ARYLOXY-)2-HYDROXY-3-ALKINYL-AMINO PROPANES AND PROCESSES FOR THEIR MANUFACTURE C.H. BOEHRINGER SOHN (DE) 1983-09-21 EP claimed
EP-0035733-B1 1-(ACYLAMINO-ARYLOXY-)2-HYDROXY-3-ALKINYL-AMINO PROPANES AND PROCESSES FOR THEIR MANUFACTURE C.H. BOEHRINGER SOHN (DE) 1983-09-14 EP claimed
EP-0084357-A1 Benzodiazepines, their preparation and medicines containing them F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft (CH) 1983-07-27 EP claimed
US-4360464-A Process for production of 1-aryloxy-aminopropane derivatives TEIKOKU HORMONE MFG. CO. LTD. (JP) 1982-11-23 US claimed
US-4267340-A BACTERICIDES; SYNTHESIS OF PENICILLINS AND CEPHALOSPORINS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1981-05-12 US claimed